Cladribine (Mavenclad) is an FDA-approved medication for treating multiple sclerosis. It works differently from other MS medications by interfering with certain immune cell processes to help control inflammation that damages nerve fibers.
The medication belongs to a class called purine antimetabolites and is given as a Show Full Answer
Cladribine (Mavenclad) is an FDA-approved medication for treating multiple sclerosis. It works differently from other MS medications by interfering with certain immune cell processes to help control inflammation that damages nerve fibers.
The medication belongs to a class called purine antimetabolites and is given as a short-course oral therapy. Important note: Cladribine can have side effects, including potential skin reactions. Since you're switching from teriflunomide (Aubagio), it's important to work closely with your healthcare team to manage the transition between medications safely.
Many MyMSTeam members have shared their experiences with various MS medications, including Cladribine. Consider discussing any specific concerns about the medication change with your neurologist, who can provide personalized guidance based on your medical history.
September 15, 2025
Join
Your Privacy Choices
